molecular medicine

See the following -

NantHealth Acquires Harris Healthcare Solutions

Press Release | NantHealth | July 16, 2015

NantHealth, a subsidiary of NantWorks, LLC, today announced it has completed the acquisition of Harris Corporation’s (NYSE:HRS) commercial Healthcare Solutions business, a clinical systems integration innovator. Harris retained its government healthcare services business. NantHealth’s existing cOS, eviti and omics platforms, combined with Harris’ FusionFX® suite of products, delivers on the promise of whole health systems integration and revolutionizes the patient-clinician experience by bringing molecular medicine insights directly to the point-of-care.

Read More »

Open Source Health announces launch of the first Women’s Precision Medicine Platform in Atlanta, USA

Press Release | Open Source Health Inc. | June 9, 2016

Open Source Health Inc....a cloud based precision medicine platform that puts control into the hands of women to educate, advocate and collaborate on their own healthcare is pleased to announce the launch of the myAva Precision Medicine Platform with it’s first cohort of women in Atlanta, GA. “After 2 years of development we are finally set to deliver precision medicine to women with PCOS” says Sonya Satveit, CEO of Open Source Health Inc. “By providing an in-depth molecular insight of each woman, myAva will help achieve a new understanding of PCOS and has the potential to provide precision treatment programs customized to each woman’s unique molecular makeup.”

Read More »